Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for OrthoPediatrics Corp. (KIDS : NSDQ)

• Company Description    OrthoPediatrics Corp. is a medical device company. It markets surgical systems for trauma and deformity, bone fractures and reconstruction procedures. OrthoPediatrics Corp. is based in NEW YORK. Number of Employees: 602

• Price / Volume Information    Yesterday's Closing Price: $18.37 Daily Weekly Monthly 20 Day Moving Average: 197,922 shares Shares Outstanding: 25.68 (millions) Market Capitalization: $471.83 (millions) Beta: 0.99 52 Week High: $23.70 52 Week Low: $14.42 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 13.32% 7.79% 12 Week 3.26% -4.54% Year To Date 3.43% -4.59%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2850 Frontier Drive - Warsaw,IN 46582 USA ph: 574-268-6379 fax: 574-269-3692 philip@gilmartinir.com http://www.orthopediatrics.com

• General Corporate Information    Officers David R. Bailey - President and Chief Executive Officer Fred L. Hite - Chief Financial Officer and Chief Operating Office Mark C. Throdahl - Director Bryan W. Hughes - Director Kelly Fische - Director Peer Information OrthoPediatrics Corp. (ABMD) OrthoPediatrics Corp. (DMDS) OrthoPediatrics Corp. (CPWY.) OrthoPediatrics Corp. (EQUR) OrthoPediatrics Corp. (ECIA) OrthoPediatrics Corp. (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 68752L100 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/04/26 Share - Related Items Shares Outstanding: 25.68 Most Recent Split Date: (:1) Beta: 0.99 Market Capitalization: $471.83 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.31 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.13 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.39 Price/Cash Flow: 110.47 Price / Sales: 1.94 EPS Growth vs. Year Ago Period: -7.69% vs. Previous Quarter: -61.54% Sales Growth vs. Year Ago Period: 13.26% vs. Previous Quarter: -3.64% ROE 03/31/26 - -7.01 12/31/25 - -6.70 09/30/25 - -6.86 ROA 03/31/26 - -4.86 12/31/25 - -4.74 09/30/25 - -4.97 Current Ratio 03/31/26 - 5.21 12/31/25 - 5.55 09/30/25 - 7.40 Quick Ratio 03/31/26 - 2.37 12/31/25 - 2.65 09/30/25 - 3.52 Operating Margin 03/31/26 - -10.02 12/31/25 - -9.91 09/30/25 - -10.61 Net Margin 03/31/26 - -16.31 12/31/25 - -16.77 09/30/25 - -20.06 Pre-Tax Margin 03/31/26 - -16.27 12/31/25 - -16.58 09/30/25 - -20.16 Book Value 03/31/26 - 13.19 12/31/25 - 13.82 09/30/25 - 13.93 Inventory Turnover 03/31/26 - 0.50 12/31/25 - 0.50 09/30/25 - 0.52 Debt-to-Equity 03/31/26 - 0.29 12/31/25 - 0.28 09/30/25 - 0.28 Debt-to-Capital 03/31/26 - 22.30 12/31/25 - 21.86 09/30/25 - 21.68

Powered by Zacks Investment Research ©